NVS - Novartis AG

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5217.52B
Enterprise Value 3233.21B
Trailing P/E 17.87
Forward P/E 116.95
PEG Ratio (5 yr expected) 12.59
Price/Sales (ttm)4.07
Price/Book (mrq)4.64
Enterprise Value/Revenue 34.36
Enterprise Value/EBITDA 614.49

Trading Information

Stock Price History

Beta (3Y Monthly) 0.55
52-Week Change 322.40%
S&P500 52-Week Change 36.52%
52 Week High 395.00
52 Week Low 30.00
50-Day Moving Average 390.06
200-Day Moving Average 383.24

Share Statistics

Avg Vol (3 month) 32.23M
Avg Vol (10 day) 32.9M
Shares Outstanding 52.29B
Float 2.18B
% Held by Insiders 10.00%
% Held by Institutions 111.69%
Shares Short (Jun 28, 2019) 44.15M
Short Ratio (Jun 28, 2019) 42.02
Short % of Float (Jun 28, 2019) 4N/A
Short % of Shares Outstanding (Jun 28, 2019) 40.16%
Shares Short (prior month May 31, 2019) 43.71M

Dividends & Splits

Forward Annual Dividend Rate 42.83
Forward Annual Dividend Yield 43.14%
Trailing Annual Dividend Rate 32.89
Trailing Annual Dividend Yield 33.20%
5 Year Average Dividend Yield 43.26
Payout Ratio 453.07%
Dividend Date 3Mar 13, 2019
Ex-Dividend Date 4Mar 4, 2019
Last Split Factor (new per old) 21000/1116
Last Split Date 3Apr 9, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 23.11%
Operating Margin (ttm)20.26%

Management Effectiveness

Return on Assets (ttm)4.95%
Return on Equity (ttm)21.11%

Income Statement

Revenue (ttm)53.46B
Revenue Per Share (ttm)23.07
Quarterly Revenue Growth (yoy)2.60%
Gross Profit (ttm)36.08B
EBITDA 16.1B
Net Income Avi to Common (ttm)12.51B
Diluted EPS (ttm)5.27
Quarterly Earnings Growth (yoy)-12.80%

Balance Sheet

Total Cash (mrq)7.05B
Total Cash Per Share (mrq)3.03
Total Debt (mrq)30.59B
Total Debt/Equity (mrq)64.66
Current Ratio (mrq)0.93
Book Value Per Share (mrq)20.33

Cash Flow Statement

Operating Cash Flow (ttm)13.67B
Levered Free Cash Flow (ttm)22.3B